Amended Quarterly Report (10-q/a)
May 19 2015 - 5:30PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q/A
(Amendment
No. 1)
[X] Quarterly
Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For
the quarterly period ended March 31, 2015
[ ] Transition
Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
For
the transition period from __________ to__________
Commission
File Number: 000-55155
Vantage
mHealthcare, Inc.
(Exact
name of registrant as specified in its charter)
Delaware |
|
93-0659770 |
(State
or other jurisdiction of
incorporation or organization) |
|
(IRS
Employer
Identification No.) |
3
Columbus Circle, 15th Floor
New
York, NY 10019
(Address
of principal executive offices)
(917)
745-7202
(Registrant’s
telephone number)
(Former
name, former address and former fiscal year, if changed since last report)
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days [X] Yes [ ] No
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X] Yes [ ]
No
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company.
[ ]
Large accelerated filer |
[ ]
Accelerated filer |
[ ]
Non-accelerated filer |
[X]
Smaller reporting company |
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X]
No
Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 217,339,610
as of May 14, 2015.
EXPLANATORY
NOTE
The
sole purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015 of
Vantage mHealthcare, Inc. (the “Company”) filed with the Securities and Exchange Commission on May 15, 2015 (the “Form
10-Q”) is to furnish Exhibits 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T.
No other
changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form
10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in
any way disclosures made in the original Form 10-Q.
EXHIBIT INDEX
Exhibit
Number |
|
Description
of Exhibit |
31.1 |
|
Certification
of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002* |
|
|
|
31.2 |
|
Certification
of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002* |
|
|
|
32.1 |
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002* |
101.INS |
|
XBRL Instance
Document** |
|
|
|
101.SCH |
|
XBRL Taxonomy
Extension Schema Document** |
|
|
|
101.CAL |
|
XBRL Taxonomy
Extension Calculation Linkbase** |
|
|
|
101.DEF |
|
XBRL Taxonomy
Extension Definition Linkbase Document** |
|
|
|
101.LAB |
|
XBRL Taxonomy
Extension Label Linkbase Document** |
|
|
|
101.PRE |
|
XBRL Taxonomy
Extension Presentation Linkbase Document** |
* These
exhibits were previously included or incorporated by reference in the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2015, filed with the Securities and Exchange Commission on May 15, 2015.
**
Provided herewith.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
|
Vantage
mHealthcare, Inc. |
|
|
|
Date: May 19,
2015 |
By: |
/s/
Joseph C. Peters |
|
Name: |
Joseph C. Peters |
|
Title: |
Chief Executive
Officer |
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Sep 2023 to Sep 2024